The use of a screening strategy based on human tumor cell lines, which are also tumorigenic in immune-deprived mice, is described. Activity 
Introduction: An Historical Perspective Strategies for identifying new anticancer agents have developed and evolved over the years from simple animal models to the incorporation of the latest techniques in molecular biology. Historically however these strategies have been predominantly based on in vivo rodent tumor models. The earliest rodent models that were used, prior to 1955, were allogeneic transplantable tumors such as Sarcoma 180, Erlich ascites, Yoshida ascites sarcoma, and the Walker 256 carcinoma. These tumors are rapidly growing, undifferentiated cell types. Being allogeneic the host animal will frequently mount an immune response to the tumor, also the solid tumors such as Sarcoma 180 are frequently sensitive to host weight loss. Both of these factors make it difficult to differentiate drug effect from host effects. In addition some of these tumors such as the Erlich ascites are very sensitive to cytotoxic agents thus leading to large numbers of false positives in the screen. As a result of these limitations the allogeneic tumor models were superseded by syngeneic transplantable murine tumors such as the L1210 and P388 leukemia's, and the Lewis Lung carcinoma, and B16 melanoma. These tumors retain their histologic type on transplantation, grow rapidly and reproducibly, and give reproducible results with control drugs, therefore satisfying many of the requirements of a screening system. They VoL 6, Nos. [4] [5] 1999 A Screening StrategyJbr Metal Antitumor Agents As Exemplified by Gold (III) Complexes The molecular target for cisplatin is DNA. '8 Cisplatin can form both inter-and intra-strand cross-links with DNA. The latter, primarily G-G cross-links, are thought to be the cytotoxic lesion. The interaction of [Au(acetato)(damp)] with DNA was investigated using two techniques, a plasmid mobility assay, and alkaline elution. The former monitors the migration of a closed circular plasmid, Col E1 in these studies, on an agarose gel. 9 The closed circular plasmid exists in two forms, a supercoiled, condensed form (RFII) and a nicked relaxed form (RFI). The RFII form migrates faster than the RFI form on the gel. Cisplatin, which can bind to the DNA, reduced the migration of the RFII form. This is due to the induction of inter-and intra-strand cross-links causing unwinding, superwinding, and rewinding of the DNA. The mobility of the RFI form was increased by similar interactions. For [Au(acetato)(damp)] no effect was observed on plasmid mobility except at the highest concentration, 1500 laM, 100 fold higher than the ICo against the HT1376 cells. This concentration is so high as to be pharmacologically irrelevant, whereas in contrast cisplatin exerted an effect at <10 tM.
The cross-linking of DNA strands can be assayed using a technique known as alkaline elution. This is a filtration technique in which the formation of DNA cross-links impedes the flow of DNA strands through a filter. This is further enhanced by performing the technique under alkaline conditions, which separates DNA double strands into single strands. Figure 5 . Cisplatin cross-linked the DNA as shown by the slower rate of elution compared with untreated controls (Figure 5a ). Strand-breakage was seen in irradiated, cisplatin treated cells (Figure 5a ). (Table 6 ). (Table 7) it is evident that cisplatin toxicity is delayed, a result of the need for the cells to proceed through a replication cycle in order for cisplatin to exert its effect, compared with [Au(acetato)=(damp)] where cell death occurs rapidly after dosing. 
